Inhaled iloprost for the treatment of Raynaud's phenomenon

Clin Exp Rheumatol. 2008 Jul-Aug;26(4):709.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Administration, Inhalation
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Iloprost / administration & dosage*
  • Male
  • Middle Aged
  • Raynaud Disease / complications
  • Raynaud Disease / drug therapy*
  • Scleroderma, Systemic / complications
  • Vasodilator Agents / administration & dosage*

Substances

  • Vasodilator Agents
  • Iloprost